Nuveen Asset Management, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,141,837
-31.8%
360,201
+6.9%
0.00%
-100.0%
Q2 2023$1,674,214
+123732.4%
336,864
+23.1%
0.00%0.0%
Q1 2023$1,352
-1.1%
273,678
+25.9%
0.00%0.0%
Q4 2022$1,367
-100.0%
217,349
-37.4%
0.00%
-50.0%
Q3 2022$3,749,000
-42.7%
347,169
-39.6%
0.00%
-33.3%
Q2 2022$6,547,000
+1.5%
574,352
-15.5%
0.00%
+50.0%
Q1 2022$6,452,000
+26.8%
679,821
+99.3%
0.00%0.0%
Q4 2021$5,089,000
-55.6%
341,054
-23.4%
0.00%
-50.0%
Q3 2021$11,450,000
-23.5%
445,530
-22.3%
0.00%0.0%
Q2 2021$14,960,000
+85.8%
573,604
+151.5%
0.00%
+33.3%
Q1 2021$8,050,000
+35.5%
228,049
-3.1%
0.00%
+50.0%
Q4 2020$5,940,000
-55.4%
235,365
-33.4%
0.00%
-60.0%
Q3 2020$13,331,000
-14.4%
353,495
-2.9%
0.01%
-16.7%
Q2 2020$15,580,000
+426.0%
363,869
+138.8%
0.01%
+500.0%
Q1 2020$2,962,000
-24.4%
152,384
+1.1%
0.00%0.0%
Q4 2019$3,918,000
-74.9%
150,795
-73.7%
0.00%
-83.3%
Q3 2019$15,618,000
+4.3%
573,027
+2.8%
0.01%0.0%
Q2 2019$14,967,000557,4320.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders